Evo Slim Ingredients: All Twenty Rows and Amounts

The panel's highest declared Daily Value at 191%, and the row with the largest body of weight research behind it. A 2013 meta-analysis of randomised trials found a small average difference in body weight; the Cochrane review published the same year rated the evidence low quality and the effect uncertain. Both pooled trials dosing mostly 200 to 1,000 mcg a day, so 67 mcg sits below the studied range while still being a sensible nutritional amount. A separate exploratory trial looked at carbohydrate craving rather than weight, which is closer to what the seller's icon set is pointing at. The NIH fact sheet is the plainest summary of what chromium is for.

The standardisation is the whole story of this row. Twenty-five milligrams at one per cent carries about a quarter of a milligram of corosolic acid, and the published review of banaba and corosolic acid describes human work using single doses roughly forty to two hundred times that. Banaba is named in the H1 of this website because it leads the botanical block and because its amount is printed, not because a quarter of a milligram matches a trial.

An Ayurvedic resin with a real randomised record and a disappointing one. The 2003 JAMA trial gave 1,000 to 2,000 mg a day of standardised guggulipid for eight weeks and LDL cholesterol did not fall; a later randomised study reached the same conclusion. At 50 mg this row is a twentieth of those amounts. It is included, and it is not dosed to the research.

Studied for blood sugar rather than for body weight. A 2019 meta-analysis found a small reduction in fasting glycaemia; the Cochrane review concluded there was not enough evidence to recommend it. Trials generally used around 2,000 mg a day, a hundred times this row.

The row where a small amount is the correct decision rather than a shortfall. The 2023 review of liquorice toxicity collects the reports of raised blood pressure, low potassium and fluid retention, and they attach to sustained intakes near 100 mg a day of glycyrrhizin. Twenty-five milligrams of extract is well under that. Anyone already taking licorice separately, or eating a lot of real liquorice, should add the two together rather than assume they are independent.

Powder, not extract, which changes the arithmetic. An umbrella meta-analysis of the obesity outcomes and an earlier review of the diabetes ones both pooled trials dosing one to six grams a day. Fifty milligrams is between a twentieth and a hundredth of that. The species is worth noting too: this is Cinnamomum zeylanicum, which carries far less coumarin than the cassia most supermarket cinnamon is.

Three milligrams. The meta-analysis of glycaemic control and a later review covering body measurements both pooled trials using 200 to 400 mg a day of leaf extract, so this row is around one per cent of the studied amount. Gymnema is the plant behind the sweet-taste suppression effect that makes this category interesting, and that effect comes from holding the leaf in the mouth rather than swallowing a capsule.

A traditional bitter with no human trial for body weight at all. The current pharmacology review covers mechanism, drug interactions and tolerability rather than outcomes, and it is the honest source to point at. Twenty-five milligrams of flower powder is a culinary amount.

The row most likely to be felt, and the hardest to compare. A meta-analysis of human capsaicin studies and a systematic review of capsaicinoids both measured amounts of capsaicinoids, generally two to ten milligrams, not amounts of powder. Ten milligrams of pepper powder carries a fraction of a milligram of them.

Traditional, aromatic, and without a human weight trial. A 2024 review of its constituents is chemistry and lead-compound work rather than clinical outcomes. Thirteen milligrams is included for the same reason juniper appears in gin: it is a familiar bitter botanical.

The second three-milligram row. Mulberry leaf is genuinely interesting because of 1-deoxynojirimycin, which slows starch digestion, and the 2007 human study used 0.8 to 1.2 g of enriched powder per dose. A later dose-finding trial went higher still. Three milligrams of extract is not in that conversation.

A trace mineral with no established Daily Value. The systematic review of oral vanadium found the trials used 50 to 300 mg a day of vanadyl sulfate, reported gastrointestinal side effects at those amounts, and judged the evidence insufficient. Two milligrams is far below all of it, which on this row is the conservative and correct decision rather than a gap.

One of two free compounds on the panel. A 2017 meta-analysis of randomised trials pooled doses of 300 to 1,800 mg a day and found an average difference of about 1.3 kg. Thirty milligrams is a tenth of the smallest of those. It is a real antioxidant at a nutritional amount rather than a therapeutic one.

The other free compound. A 2024 meta-analysis in adults with overweight or obesity pooled supplementation at 1.5 to 6 g a day. Twenty-five milligrams is roughly a hundredth of that, and less than a cup of tea contributes on its own.

Thirty per cent of the Daily Value, which is a genuine nutritional contribution, in the salt with the poorest absorption record of the common ones. A controlled comparison against magnesium diglycinate is the usual citation for that, and the NIH fact sheet covers what magnesium is for. What is not absorbed stays in the gut, which is why this is the row most likely to be noticed in the first week.

Seventy-three per cent of the Daily Value, a sensible daily amount. The dose-response meta-analysis on body weight used 20 to 100 mg, so this row is nutrition rather than intervention. The NIH fact sheet is worth reading before stacking it with a multivitamin, because zinc and copper compete.

Ten times the adequate intake for an adult, and the row with the only consequence that shows up inside a week. It is not a safety problem. At supplemental amounts biotin distorts several common immunoassays, including some thyroid and cardiac markers, and the FDA published a safety communication about exactly that. The reading moves, not the patient. Mention it before blood is drawn.

Fifty-six per cent of the Daily Value. A 2024 review of vitamin C requirements and body size is the relevant reading: requirements appear to rise with body mass, which makes an ordinary amount here reasonable rather than decorative.

Forty-seven per cent of the Daily Value, in the synthetic form. The NIH fact sheet covers the difference between the natural and synthetic forms and the upper intake level, which this amount is nowhere near.

Forty-three per cent of the Daily Value, and the quietest row on the panel. The NIH fact sheet sets out what manganese does and where the intake ceiling sits. One milligram is an ordinary supplemental amount.